Clinical Trial Update: An Open-Label Extension Trial to Assess the Safety of Long-Term Treatment of Rotigotine in Advanced-Stage Parkinson's Disease [Phase 3]

View source ↗

Summary

This open-label extension trial assesses the long-term safety of rotigotine in patients with advanced Parkinson's disease in a Phase 3 study; results were poste…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Neupro (rotigotine)

Snippet

Sponsor: UCB Pharma | Conditions: Advanced Stage Parkinson's Disease | Phase 3 | Status: COMPLETED | Results posted: 2010-01-12